Unlocking the Potential: Advancements in ADC Therapy for Metastatic Triple Negative and HER+/HER2- Breast Cancer Treatment

Requirements: Ideal Group Leaders are MDs or DOs with specialized clinical expertise in treating and managing patients with metastatic triple-negative breast cancer (mTNBC) and HER+/HER2- breast cancer.

If you already have a Gather-ed account, please log in here

Email:
Password:

Apply for Group Leader

Step 1 of 3